An international task force made up of a panel of 16 experts was mandated to review and objectively evaluate all aspects of chronic venous disease of the leg. All available publications on chronic venous disease of the leg from 1983 to 1997 were identified through computerized search. Three different screenings were then performed in order to select only relevant papers providing moderate to strong scientific evidence. Final conclusions and further therapeutic recommendations were made based on these publications. Compression, medications, local therapies, sclerotherapy and surgery are the existing therapeutic options for which the following recommendations can be made. Compression: Properly applied bandages both fixed and stretched have been shown to be effective. Compression stockings may be used. Compression needs to be in excess of 35 mm Hg. Medications: Although preliminary results have shown a beneficial effect of several vasodilators and oral micronized purified flavonoid fraction, the evidence for the efficacy of medications on venous ulcer healing is still limited and further studies are required before recommendations can be made. There is no evidence to routinely administer antibiotics. Local therapies have an as yet unproven adjunctive role. Sclerotherapy is unlikely to be effective unless there is superficial venous insufficiency, in which it may have an as yet unproven role. Surgery: Patients with active venous ulcer and sapheno-femoral or sapheno-popliteal junction incompetence benefit from surgical treatment. In the absence of reflux or following deep vein thrombosis, there is no evidence to support surgical treatment.

1.
Porter JM, Moneta GL and an International Consensus Committee on Chronic Venous Disease: Reporting Standards in venous disease: An update. J Vasc Surg 1995;21:635–645.
2.
Abenhaim L, Kurz X, Norgren L, Clement DL and the VEINES Task Force (eds): The management of chronic venous disorders of the leg (CVDL): An evidence-based report on an International Task Force. Under the Auspices of: The VEINES (VEnous INsufficiency Epidemiologic and Economic Studies) program, McGill University, Sir Mortimer B. Davis-Jewish General Hospital, 1998.
3.
Colgan MP, Dormandy JA, Jones PW, Schraibman IG, Shanik DG, Young RA: Oxpentifylline treatment of venous ulcers of the leg. Br Med J 1990;300:972–975.
4.
Guilhou JJ, Dereure O, Marzin L, Ouvry P, Zuccarelli F, Debure C, Van Landuyt H, Gillet-Terver M-N, Guillot B, Levesque H, Mignot J, Pillion G, Février B, Dubeaux D: Efficacy of Daflon 500 mg in venous leg ulcer healing: A double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997;48:77–85.1
5.
Alinovi A, Bassissi P, Pini M: Systemic administration of antibiotics in the management of venous ulcers – A randomized clinical trial. J Am Acad Dermatol 1986;15:186–191.
6.
Wright DDI, Franks PJ, Blair SD, Backhouse CM, Moffat CJ, McCollum CN: Oxerutins in the prevention of recurrence in chronic venous ulceration: Randomized controlled trial. Br J Surg 1991;78:1269–1270.
7.
Kalis B: Appréciation par la mesure de la pO2 transcutanée d’un traitement des ulcères veineux par le naftidrofuryl. J Mal Vasc 1984;9:133–136.
8.
Skog E, Arnesjö B, Troëng T, Gjöress JE, Bergljung L, Gundersen J, Hallbook T, Hessman Y, Hilstrom L, Mansson T, Eilard U, Ekloff B, Plate G, Norgren L: A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers. Br J Dermatol 1983;109:77–83.
9.
Parvulesco J: Micro-coagulo-chirurgie – Nouvelle thérapie esthétique des varicosités télangiectasiques. Phlébologie 1991;44:213–200.
10.
Rasmussen LH: Evaluation of recombinant human growth hormone for wound management. Dan Med Bull 1995;43:358–370.
11.
Belcaro G, Marelli C: Treatment of venous lipodermatosclerosis and ulceration in venous hypertension by elastic compression and fibrinolytic enhancement with defibrotide. Phlebology 1989;4:91–106.
12.
Ormiston MC, Seymour MTJ, Venn GE, Cohen RI, Fox JA: Controlled trial of lodosorb in chronic venous ulcers. Br Med J 1985;291:308–310.
13.
Callam MJ, Harper DR, Dale JJ, Brown D, Gibson B, Prescott RJ, Ruckley CV: Lothian and Forth Valley leg ulcer healing trial. 1. Elastic versus non-elastic bandaging in the treatment of chronic leg ulceration. Phlebology 1992;7:136–141.
14.
Kikta MJ, Schuler JJ, Meyer JP, Durham JR, Eldrup Jorgensen J, Schwarcz TH, Flanigan DP: A prospective, randomized trial of Unna’s boots versus hydroactive dressing in the treatment of venous stasis ulcers. J Vasc Surg 1988;7:478–486.
15.
Moffat CJ: An evaluation of community leg ulcer clinics. Phlebology 1992;7:283–285.
16.
Coleridge Smith P, Sarin S, Hasty J, Scurr JH: Sequential gradient pneumatic compression enhances venous ulcer healing: A randomized trial. Surgery 1990;108:971–975.
17.
Smith JM, Doré CJ, Charlett A, Lewis JD: A randomized trial of biofilm dressing for venous leg ulcers. Phlebology 1992;7:108–113.
18.
Stacey MC, Burnand KG, Layer GT, Pattison M: Calf pump function in patients with healed venous ulcers is not improved by surgery to the communicating veins or by elastic stockings. Br J Surg 1988;75:436–439.
19.
Stöberl C, Gabler S, Partsch H: Indikationsgerechte Bestrumpfung – Messung der venösen Pumpfunktion. Vasa 1989;18:35–39.
20.
Raju S, Fredericks R: Valve reconstruction procedures for nonobstructive venous insufficiency: Rationale, techniques, and results in 107 procedures with two- to eight-year follow up. J Vasc Surg 1988;7:301–310.
21.
Perrin M, Gobin JP, Grossetête C, Henry F, Lepretre M: Valeur de l’association chirurgie litérative-sclérothérapie après l’échec du traitement chirurgical des varices. J Mal Vasc 1993;18:314–319.
22.
Bradbury AW, Stonebridge PA, Callam MJ, Ruckley CV, Allan PJ: Foot volumetry and duplex ultrasonography after saphenous and subfascial perforating vein ligation for recurrent venous ulceration. Br J Surg 1993;80:845–848.
23.
Callam MJ, Dale JJ, Harper DR, Ruckley CV, Prescott RJ: A controlled trial of weekly ultrasound in chronic leg ulceration. Lancet 1987;ii:204–206.
24.
Bradbury AW, Ruckley CV: Foot volumetry can predict recurrent ulceration after subfascial ligation of perforators and saphenous ligation. J Vasc Surg 1993;18:789–795.
25.
Mayberry JC, Moneta GL, De Frang RD, Porter JM: The influence of elastic compression stockings on deep venous hemodynamics. J Vasc Surg 1991;13:91–100.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.